Deans' stroke musings: Zynex Obtains European Patent for Blood Volume Monitor

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, February 4, 2020

Zynex Obtains European Patent for Blood Volume Monitor

If one were smart you would think stroke hospitals would use this post tPA to immediately identify those cases of brain bleeds and work to stop them. IF YOU WERE SMART!

Zynex Obtains European Patent for Blood Volume Monitor

ENGLEWOOD, Colo., Feb. 3, 2020 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has obtained a European patent for its Blood Volume Monitor Device. Thomas Sandgaard, the inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.

Thomas Sandgaard, CEO said: "I am excited to have obtained European patent protection for the core principles of how we detect fluid imbalances such as excessive blood loss during surgery or internal bleeding in recovery. We received a U.S. Utility Patent protection on the device about a year ago and believe this will strengthen our competitive position in the market for better fluid management in hospitals and surgical centers. This breakthrough technology is unique as there are no other non-invasive devices available that can detect blood loss or internal bleeding.

We believe our non-invasive, easy-to-operate technology will serve an unmet need to manage blood volume in hospital and surgical settings, whether it is fluid loss, fluid overload or internal bleeding which is rarely detected until it becomes critical or fatal. It should be noted, we are still awaiting FDA clearance and European CE marking to fully launch the product into the market.

We believe lives can be saved with this technology as significant complications are avoided during surgery. Fluid management issues can cause organs to malfunction and make recovery more difficult.